Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

News

December 22, 2014 — Veniti Inc. announced that it has enrolled the first United States patients in the Virtus trial of ...

Home December 22, 2014
Home
News

December 10, 2014 — In the first successful United States trial of a bioabsorbable polymer stent, the Boston Scientific ...

Home December 10, 2014
Home
News
November 25, 2014 — CeloNova BioSciences, Inc., announced that positive frst-in-man (FIM) clinical trial results found ...
Home November 25, 2014
Home
DAPT study
Feature
November 18, 2014 — Patients who took dual antiplatelet therapy medications beyond the standard 12 months after coronary ...
Home November 18, 2014
Home
News

Nov. 14, 2014 — Micell Technologies Inc. announced commercialization plans for its MiStent Sirolimus Eluting Absorbable ...

Home November 14, 2014
Home
News

Nov. 13, 2014 — Optimizing the treatment of coronary artery disease with a new foundation for future stent innovations ...

Home November 13, 2014
Home
News

November 11, 2014 — Five-year results from the largest and longest-running clinical trial of a drug-eluting stent for ...

Home November 11, 2014
Home
VIVA, VIVA Physicians, Peripheral, Carotid Artery Device, clinical trial results
Feature

Nov. 11, 2014 — Viva Physicians, a not-for-profit organization in the field of vascular medicine and intervention ...

Home November 11, 2014
Home
Technology

November 4, 2014 — The U.S. Food and Drug Administration (FDA) has cleared the Abbott family of Xience everolimus ...

Home November 04, 2014
Home
News

By Dave Fornell, editor of DAIC Magazine

The key take away messages from the 26th annual Transcatheter Cardiovascular ...

Home November 03, 2014
Home
Technology

Oct. 27, 2014 — The U.S Food and Drug Administration (FDA) cleared the EverFlex Self-Expanding Peripheral Stent System ...

Home October 27, 2014
Home
News

October 23, 2014 — The use of stents has improved management and outcomes of coronary artery disease, and clinical ...

Home October 23, 2014
Home
News

October 20, 2014 — Boston Scientific Corp. has initiated the PLATINUM Diversity trial to evaluate the clinical ...

Home October 20, 2014
Home
News

October 16, 2014 — Using stents to keep neck arteries open is just as effective as invasive neck surgery for long-term ...

Home October 16, 2014
Home
Feature

October 8, 2014 — Abbott announced the start of the ABSORB IV clinical trial, which will test whether the Absorb bioreso ...

Home October 08, 2014
Home
Subscribe Now